pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

Strona główna・Stock List・Arrowhead Pharmaceuticals Inc
Search

Arrowhead Pharmaceuticals Inc

Closed

Sector Healthcare

17.68 -0.73

Buy

Price update 10 paź 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

17.01

Max

17.81

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+140.47 upside

Dividends

By Dow Jones

Next Earnings

27 lis 2024

News Sentiment

By Acuity

72%

28%

352 / 366 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

N/A / 17.235 Support & Resistance

Arrowhead Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 wrz 2024, 10:38 UTC

Major Market Movers

Arrowhead Pharmaceuticals Shares Climb on Plans to File New Drug Application for Plozasiran

DJ

Read

Peer Comparison

Price change

Arrowhead Pharmaceuticals Inc Forecast

Price Target

By TipRanks

140.47% upside

12 Months Forecast

Average 42.9 USD  140.47%

High 62 USD

Low 20 USD

Based on 11 Wall Street analysts offering 12 month price targets forArrowhead Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

7

Buy

4

Hold

0

Sell

Based on 11 analysts giving stock ratings to Arrowhead Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 17.235Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

352 / 366 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Other stocks from the sector

LLY

Eli Lilly and Co.

911.36

↓-1.01%

UNH

UnitedHealth Group Inc

597.64

↑ +0.96%

NVO

Novo Nordisk A-S

117.53

↑ +0.34%

JNJ

Johnson and Johnson

160.64

↓-0.12%

ABBV

AbbVie Inc

194.4

↓-0.21%